Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis - Wikidata - awgldk - TriplyDB

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

http://www.wikidata.org/entity/Q28363481

about

Apparent mineralocorticoid excess syndrome: an overview DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice.Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.Reduced cortisol metabolism during critical illness Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum.Born from pre-eclamptic pregnancies predisposes infants to altered cortisol metabolism in the first postnatal year.Dysregulation of ENaC in Animal Models of Nephrotic Syndrome and Liver Cirrhosis Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.Sodium retention in rats with liver cirrhosis is associated with increased renal abundance of NaCl cotransporter (NCC).Influence of human serum albumin on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase.Adrenal function in cats with cholestatic liver disease.Hypokalaemia in a hyperthyroid domestic shorthair cat with adrenal hyperplasia.Increased cortisol metabolism in women with pregnancy-related hypertension.Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.

P2860

Q28239329-71B2199F-9B12-455F-B6E3-E1CF8E53138C Q28573234-D79190A8-036D-44FB-91EF-C765225C26F1 Q33713631-3C16648C-F67F-4A10-BD50-A35B7DF721A0 Q33882285-658129EF-7478-4A1B-9526-9B5F8234815F Q35549611-3F4BB6CC-0ABC-4CC0-9DCD-9EEB0DE60BE3 Q36024380-DB561878-8217-45B6-99BE-251F5FEC63E5 Q36210761-A37C1350-0CC2-4BFB-B3EC-ABFF0B55FB9A Q37489207-D022F650-C099-4A46-BDF4-F0FFE6C6CDBB Q39904526-0E63B160-DB6E-4AD9-9D2B-DAAB2E96A544 Q46546917-23AB02C6-9E81-4645-9C17-8F13FBCDB93D Q46854402-4B86E4E8-1ADA-49A6-929A-8C24E499F8D8 Q47364850-60E0DD8B-4F0E-4538-A38B-172340D47AFA Q51154353-E70D74B6-3F5A-4B74-8C2D-C57300C6BAE0 Q55340062-5AE9311C-3E6A-43FF-AA70-6CCABC6046BE Q55638445-9BE75466-D79C-4492-AB36-D519B6375C4F

P2860

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

http://www.wikidata.org/entity/Q28363481

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@ast

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@en

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@nl

type

label

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@ast

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@en

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@nl

prefLabel

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@ast

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@en

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@nl

P1433

Q28363481-F260E535-2933-4D5E-B4F4-6ABB01070831

P1476

Q28363481-FD8DE510-2E7C-4370-87DE-0010F4DF8D28

P2093

Q28363481-05DEC60E-5DEC-4F50-AF6D-2CC431D65955

Q28363481-08150E98-16EE-4DDE-9CE9-49F694B49C70

Q28363481-4D480530-2193-4C01-A33D-FD4DFF4F9074

Q28363481-604B6D8C-B86E-4EC7-BEBB-0C796C6CCAAA

Q28363481-A057E156-583C-428E-A622-F86C9F3E2576

Q28363481-AC6A6067-FA24-479B-B3E8-D72221DFFED5

P2860

Q28363481-098F95A0-D5AA-46EA-B2C6-043215F14CF3

Q28363481-1D513175-72FD-4CE9-9344-A2B1598FD6DC

Q28363481-34BCE54F-2696-4182-B0EE-C8BA17125C13

Q28363481-45D5AD33-AB2A-41A3-B6E0-D92C4E2604F2

Q28363481-50883DE5-1F07-4AE8-8981-EFBDF0BA5C05

Q28363481-5254B6B7-9ABE-4387-8659-053FB829AFCB

Q28363481-58BC1582-D3C4-486F-8685-C6F4083E2905

Q28363481-5E5B3E2C-03CF-4E8E-B4B4-ED68C84A79B0

Q28363481-68565888-3FFC-461C-839C-2C2A672F0F4D

Q28363481-688D1697-C885-41F3-9B9A-F07341DF1D72

P304

Q28363481-5EC885FD-12EC-4AB4-9247-979FBE94A86B

P31

Q28363481-C51C7D9D-D762-48D2-9D67-1A69CCDA6D9E

P356

Q28363481-DC5F5D0E-F027-494D-9FB9-10830E4C29B6

P407

Q28363481-F5028356-288E-405B-A5FC-A3460013C470

P433

Q28363481-A0D3B739-401B-4E00-B937-45EA2716045D

P478

Q28363481-1DAA0D99-F900-4288-B6E7-CF450E12FB1F

P577

Q28363481-EC85CFC7-7FE6-4049-B053-9F8B4B460B34

P5875

Q28363481-AE429FC3-CB6F-41D5-987D-6ACF7294893F

P698

Q28363481-FDBC3F1B-E323-4F72-BC42-ED73B6C9EDCD

P932

Q28363481-B603FC9A-11F3-43FA-949C-B589BD58898F

P356

P1433

Journal of Clinical Investigation

P1476

Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis

@en

P2093

A Odermatt

http://www.w3.org/2001/XMLSchema#string

B Dick

http://www.w3.org/2001/XMLSchema#string

B M Frey

http://www.w3.org/2001/XMLSchema#string

B Vogt

http://www.w3.org/2001/XMLSchema#string

C Quattropani

http://www.w3.org/2001/XMLSchema#string

F J Frey

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane

Renal sodium retention during upright posture in preascitic cirrhosis

Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age

Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.

In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.

P304

1299-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI12745

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11657016

http://www.w3.org/2001/XMLSchema#string

P698

11696574

http://www.w3.org/2001/XMLSchema#string

P932

209437

http://www.w3.org/2001/XMLSchema#string